FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

MODIFICATION TO VARIANT II: HEMOGLOBIN A1C PROGRAM, BETA-THALASSEMIA SHORT PROGRAM AND TOTAL GHB PROGRAM

K Number: K063643 · Decision Dec 27, 2006
Classifications
1
FEI Numbers
65
Registration Numbers
65
Same Product Code
248
Applicant Total
3
Review Days
20

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
MODIFICATION TO VARIANT II: HEMOGLOBIN A1C PROGRAM, BETA-THALASSEMIA SHORT PROGRAM AND TOTAL GHB PROGRAM
K Number
K063643
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
864.7470
Medical Specialty
Hematology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Bio-Rad Laboratories Inc., Clinical Systems Divisi
Date Received
December 7, 2006
Decision Date
December 27, 2006
Product Code
LCP
Advisory Committee
Hematology
Review Advisory Committee
CH
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LCP Assay, Glycosylated Hemoglobin

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LCP), ordered by most recent decision date.

View all

Other Clearances by Bio-Rad Laboratories Inc., Clinical Systems Divisi

K Number Device Name
K080911 VARIANT NBS SICKLE CELL PROGRAM REAGENT KIT, VARIANT NBS NEWBORN SCREENING SYSTEM AND VARIANT NBS WORKSTATION WITH
K070819 VARIANT II TURBO LINK HEMOGLOBIN A1C PROGRAM, AND VARIANT II TURBO LINK HEMOGLOBIN TESTING WITH MODEL, 270-2716,